Gritstone bio, Inc. (GRTS)
| Previous Close | 2.6400 |
| Open | 2.5900 |
| Bid | 2.6500 x 1800 |
| Ask | 2.6600 x 900 |
| Day's Range | 2.5900 - 2.7600 |
| 52 Week Range | 1.7100 - 14.4200 |
| Volume | |
| Avg. Volume | 865,396 |
| Market Cap | 197.484M |
| Beta (5Y Monthly) | 0.41 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.5440 |
| Earnings Date | Nov 01, 2022 - Nov 07, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.33 |
- GlobeNewswire
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the company’s Board of Directors granted three employees nonqualified stock options to purchase an aggregate of 12,400 shares of its common stock with an exercise price of $3.59, which is equal to the closing price of Gritstone’s common stock on September 9, 2022, the last trading day precedin
- GlobeNewswire
Gritstone Presents Positive Initial Phase 2 Data in Late-Line Solid Tumor Patients Treated With KRAS-Directed Immunotherapy (SLATE) at ESMO 2022
-- SLATE vaccines (version 1 and SLATE-KRAS) demonstrate early evidence of efficacy with a 39% molecular response rate in evaluable patients with late-line microsatellite-stable colorectal cancer (MSS-CRC) and non-small cell lung cancer (NSCLC) -- -- Molecular response, as measured by reduction in circulating tumor DNA (ctDNA) from baseline, demonstrates a correlation with overall survival (OS) in NSCLC, consistent with industry literature -- -- SLATE-KRAS vaccine candidate elicits robust KRAS n
- GlobeNewswire
Gritstone to Participate in Two Upcoming Investor Conferences
EMERYVILLE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that management will present at the 2022 Wells Fargo Healthcare Conference, taking place September 7-9, 2022, in Boston, MA, and participate in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference, taking place September 12-14, 2022, in New York, NY. The events will also
